These conversations often take place when professionals are reassessing their next move, sometimes following restructures, leadership changes, or shifts within their organisation.

While this is not a statistical sample, clear patterns are beginning to emerge.

Below are five signals shaping career movement in MedTech right now.

---

1. Restructures Are Driving Unexpected Career Moves

A recurring trigger for career movement is organisational restructuring rather than voluntary resignation or dissatisfaction.

Several professionals described roles disappearing or changing significantly due to cost rationalisation, portfolio shifts, or leadership changes. In many cases the individual had not been actively planning a move prior to the restructure.

These transitions often happen quickly and leave candidates navigating the market earlier than expected.

---

2. Employers Are Scrutinising Stability More Closely

Tenure continues to matter in MedTech hiring.

Candidates with several recent moves are aware that hiring managers may view short stints cautiously, particularly in senior commercial roles. As a result, professionals are increasingly conscious of how career transitions appear on a CV and how they explain those moves during interviews.

The perception of stability remains an important factor in leadership hiring decisions.

---

3. The Market Still Runs on Networks

Even when professionals have access to formal outplacement support or recruiters, the most common strategy for navigating a career move remains personal networks.

Industry relationships, former colleagues, and informal introductions continue to play a significant role in uncovering opportunities.

For many senior professionals, the visible job market represents only a small portion of potential roles.

---

4. Alignment Is Becoming More Important Than Titles

Several professionals described using a career transition to reassess the type of work they want to do.

Rather than simply moving to the next available leadership role, candidates are increasingly interested in positions that align with their background or interests. In MedTech this often means reconnecting with the clinical, scientific, or technical side of the industry.

Fit and long-term alignment are becoming more important considerations than title alone.

---

5. Explaining Career Movement Is Part of the Strategy

Professionals are increasingly aware that employers expect a clear narrative around career changes.

Candidates who have recently been promoted, changed companies, or experienced a restructure are thinking carefully about how those transitions will be interpreted by hiring managers.

Being able to articulate the context behind a move has become an important part of navigating the market.

---

If you’re seeing similar patterns across the sector, I’d be interested to hear your perspective.

Leave a comment

About These Signals

These insights are drawn from confidential conversations with senior MedTech professionals between September 2025 and March 2026.

They are not statistical findings but directional signals from experienced individuals navigating leadership careers in the sector.

Future editions will continue tracking how these patterns evolve across the MedTech sector.

Richard Duke is the founder of DukeMed, a specialist executive search firm focused on the MedTech sector.

---

For senior leaders, the challenge has shifted from simple “headcount” to Commercial Precision.

If your organisation is cycling through the same job boards and sifting through overwhelming applicant pools without filling critical seats, the issue isn’t the talent pool—it very likely is your hiring strategy.

1. The Hidden Cost of Reactive Hiring

Most organisations only engage in a search once a resignation letter hits the desk. In MedTech, where specialist expertise is the currency of growth, an empty territory for six months is a direct hit to market share.

The Shift: Move from “Filling Vacancies” to “Building a Bench”.

The Intelligence: You must understand the “Ghost Market”—high-performing passive candidates currently hitting their targets at your competitors who will never see your job ad they are “invisible”.

2. The Internal-Only Trap: Why Familiarity Stifles Innovation

Leaders often hesitate to hire external mid-career leadership, defaulting instead to internal promotions for “perceived security”. While loyalty is vital, relying solely on internal pipelines creates a “Cross-Pollination Gap”.

The Reality: External hires bring fresh perspectives and the playbooks of your competitors, which is crucial for navigating today’s headwinds like reimbursement reform and margin pressure.

3. From “Perks” to “Equity”: The EVP Evolution

In 2022, you could win talent with a “culture of free coffee”. In 2026, top-tier MedTech talent is risk-averse. They want to know your commercial viability, your technical pipeline, and your path to bonus or equity.

The Strategy: Your Employee Value Proposition (EVP) must be a Business Case, not a lifestyle pitch.

4. Reducing Risk with Data-Led Assessment

“He seems like a good guy” is not a valid assessment criteria. High-stakes hiring requires rigorous behavioural assessment for competencies like Stakeholder Mapping and Commercial Acumen.

The Verdict: By utilising search-led hiring “QIA” based shortlisting and sentiment analysis, you replace “gut feel” with a structured 360-degree view of long-term potential.

5. The Search-Led Insurance Policy

The most successful MedTech leaders in 2026 treat talent acquisition like an insurance policy. They don’t wait for a “Critical Fail” in a territory to start the search process. Instead, they invest in Talent Mapping and Search Intelligence to ensure that when a transition occurs, the “Bench” is already identified and vetted.

The Bottom Line: If your current recruitment process relies on chance, you are leaving your market share to chance. In a high-stakes industry, “Good Enough” hiring is a strategy for stagnation.

Context before commitment.

​Whether you’re hiring in MedTech or sense-checking your own career direction, DukeMed starts with context — not assumptions.

Is your hiring process built for 2022 or 2026?

Don’t let a flawed strategy cost you another quarter of growth. Use our diagnostic tool to identify the specific bottlenecks or gaps in your current hiring model.

RUN THE PRE-HIRE DIAGNOSTIC 🔬

Analyze your search readiness in 2 minutes 🚦

Alternatively, book a confidential 1-on-1 with us from “Quick Question to Full Hire Strategy Playbook ”

BOOK A DISCOVERY CALL 👥

PS - if you have got something more immediate (or time-sensitive ), then feel free to start the conversation or call Richard Duke on +61279121168

In a tight talent market, the Counteroffer is inevitable.

But for both the Employee and the Employer, the data suggests it is almost always a mistake.

The scenario is standard: A high-performing Territory Manager resigns.

The Sales Director, fearing a vacant territory and lost revenue, immediately matches the offer + 10%.

The candidate accepts. Crisis averted?

No. You haven’t saved the employee; you have just rented them for another quarter.

The money has changed, but the root causes—lack of autonomy, blocked progression, or culture—remain.

For the Employer: Buying Time, Not Loyalty

Why do companies counter?

It is rarely about “love.”

It is about Operational Risk Management 🛡️.

1. Project Continuity: They need the employee to finish the Q1 launch.

2. Optics: Having to explain a resignation to the Global VP.

3. Cost: It is cheaper to pay someone $10k more now than to pay a $30k search fee tomorrow.

The Risk: If you make a counter-offer and word gets around ( it often does! ), you are signaling that the only way to get a raise in your business is to hold a gun to your head. This sets a dangerous precedent for the rest of the team.

The Outcome: Many managers who counter immediately start looking for a replacement behind the scenes. They are buying 3 months of stability while they find someone “loyal.”

For the Candidate: The “Loyalty Tax” ( & The PIP Risk )

If you accept a counteroffer, you haven’t won.

You have painted a target on your back 🎯.

1. The Broken Trust

You are now the person who “tried to leave.” When the next promotion comes up, will they give it to the flight risk? Or will they give it to the person who stayed?

2. The PIP Trap (Performance Improvement Plan)

An employee accepts a counteroffer, trains the team on their key accounts, and is then managed out via a Performance Improvement Plan (PIP) three months later. The company used the counteroffer to extract your IP before firing you.

3. The “Band-Aid” Fix

The raise buys your compliance, not your happiness. The frustration that led you to take my call—the micromanagement, the lack of new products, the territory size—will return in 90 days.

​Conclusion:

The best career moves are decisive, and the best hires are planned with insight, context not knee-jerk reactions.

Hiring Managers:

Build a pipeline of “Warm Bench” talent or map the best in your field so you never have to panic-counter.

Candidates:

Leave Clean 🌱. If you resign, mean it. Leave on good terms, but leave.

Share Inside MedTech Hiring

Stop Losing Deals at the Finish Line 🏁

Is your hiring process leaking value at the offer stage?

We can help you audit your “Closing Ratio” 🔎

Find your ideal session

​

​

This foundational guide was originally developed in 2022 and has been calibrated for the 2026 MedTech landscape.

Introduction: From “Volume” to “Value”

In 2022, the challenge was volume—finding anyone to fill a seat. Remember those times?

In 2026, the challenge is precision—finding the right commercial profile that can deliver immediate ROI in a tighter economic climate.

The “Post-and-Pray” method (posting ads and hoping for the best) no longer works for leadership or critical commercial roles. The top 15% of the market has gone underground.

They are not reading job ads, they are tired of the noise and despite recruiters or HR living on Linkedin - top talent doesn’t spend their time showing up here daily

Here are the 5 strategic shifts MedTech leaders must make to secure top talent this year.

1. Shift from “Inbound” to “Outbound”

The Old Way: “We need a Territory Manager. Let’s post an ad on LinkedIn.”

The 2026 Reality: High-performing sales professionals are not looking for jobs. They are busy hitting their targets.

The Strategy: You must treat recruitment like lead generation. Identify the “Ghost Market” (passive candidates) at your competitors and approach them directly. If you rely on applicants, you are only seeing the unhappy or the unemployed.

2. Shift from “Selling Perks” to “Selling Equity”

The Old Way: “We have a great culture like a family and free coffee or parking.”

The 2026 Reality: Candidates are risk-averse. They want to know the commercial viability of your product. Does it have a solid runway? Reimbursement? Demonstratable clinical advantages?

The Strategy: Your Employee Value Proposition (EVP) must be commercial too. Can you show them the pipeline? The reimbursement strategy? The path to equity or bonus? You are selling a business opportunity, not a lifestyle.

3. Shift from “Slow Process” to “The 4-Week Sprint”

The Old Way: A 3-month process with gaps between interviews.

The 2026 Reality: “Time kills all deals.” Top talent is on the market for 10 days, not 10 weeks.

The Strategy: Do not start interviewing until you can commit to a timeline. A structured 4-6 Week Sprint (Briefing>Market Map>Interviews>Offer) keeps momentum high and prevents counteroffers from creeping in.

​

4. Shift from “Gut Feel” to “Data-Led Assessment”

The Old Way: “I liked him, he seems like a good guy ( or gal )”

The 2026 Reality: “Good guys” can still miss targets.

The Strategy: Use rigorous behavioral assessment. Assess for specific competencies: Commercial Acumen, Territory Planning, and Stakeholder Mapping. We don’t ask “What did you do?”; we ask “How did you construct the deal?”

5. Shift from “filling a vacancy” to “building a bench”

The Old Way: Waiting for a resignation letter before calling a recruiter.

The 2026 Reality: By the time you start looking, you have already lost a quarter of revenue.

The Strategy: Proactive Pipelining & Talent Mapping. You should know who the top 3 replacements for your National Sales Manager are right now, even if she or he is happy. This is “Insurance Policy” hiring.

Conclusion: Don’t Use a 2022 Map for 2026 Terrain

The Medtech hiring market has matured. Your hiring strategy must mature with it.

Stop looking for applicants.

Start searching for talent.

Ready to understand your hiring playbook gaps?

> Run the 2-Minute Pre-Hire Diagnostic

The transition from clinical practice or pharmaceuticals into MedTech is not simply a job change. It is a shift in professional operating model.

Over the past two years, a consistent pattern has emerged among clinicians and pharmaceutical sales professionals exploring this move. The motivations are familiar: progression ceilings, income stagnation, physical burnout, or the desire to operate at a broader commercial level.

On paper, the move appears logical.

In practice, the failure rate is higher than most anticipate.

The issue is rarely intelligence or clinical credibility.

It is the gap between clinical expertise and commercial ownership.

The transition generally falls into two common pathways — and the friction points are predictable.

This piece outlines where that gap most commonly appears — and why it filters capable professionals out of competitive MedTech mandates.

The transition generally falls into three main pathways into MedTech: Nursing, Allied Health, and Pharma.

Pathway 1: The Clinical Nurse & Allied Health Pivot

The Advantage: You speak the language. You know the patient journey. You have procedural credibility with surgeons or decision makers because you have “stood next to them in the trenches” within the OR or other departments.

Where It Breaks Down: The Commercial Switch

In a hospital, care is dictated by patient need.

In MedTech, activity is dictated by commercial viability.

The most common friction is not product knowledge.

It is the ability to articulate revenue accountability.

Across recent readiness diagnostics, fewer than one-third of clinically trained candidates could clearly demonstrate commercial ownership language in early-stage interviews. The gap was rarely technical — it was commercial framing.

The pressure of quota, shrinking team structures, and higher financial targets changes the rhythm of work significantly.

The strongest clinical transitions occur when sales is reframed not as persuasion — but as structured clinical advocacy tied to measurable commercial outcomes.

Pathway 2: The Pharma Transition

The Advantage

You understand territory management. You are disciplined in CRM usage. You operate within call cycles and performance metrics.

Where It Breaks Down: Technical Grit & Procedural Immersion

Pharma sales is often process-driven and data-informed around prescribing behaviour.

MedTech — particularly orthopaedics, capital equipment and surgical portfolios — is technical, procedural, procurement-heavy and stakeholder-complex.

The difference is experiential.

In Pharma, engagement may be short-form and repeat-based.

In MedTech, especially surgical, you may be scrubbing in at 6:00am to support a complex case — where technical precision matters more than a polished pitch.

Autonomy increases.

So does accountability.

The scripted rep model does not translate well into an operating theatre environment.

Technical competence, resilience and relationship depth replace presentation gloss.

What Hiring Managers Actually Look For

Regardless of your background, MedTech leaders assess three transferable traits:

1. Commercial Drive (The “Why”)

Leaving a profession because you are “burnt out” is not enough.

You must be running towards a commercial challenge. Are you ready for a 20% quota increase while team sizes shrink?

2. Resilience Under Financial Pressure (The “Grit”)

Quota increases. Territory compression. Procurement scrutiny. Irregular hours. The surgical territory is not structured around lifestyle optimisation.

3. Network Intelligence

The “Invisible Market” applies here.

The best roles are not on Seek or job boards. The proof of strongest candidates is their ability to map their market and identify decision-makers to approach or engage with before they even get an interview.

Clinical skill gets you considered.

Commercial ownership gets you hired.

Where Candidates Attempt to Close the Gap

Don’t just rely on your degree.

To move into MedTech, you must proactively solve the “Experience Gap” before the interview.

• Targeted Research: Pivot to an area related to your current expertise. If you are a Cardiac Nurse, look at Cardiac Rhythm Management. If you sell Orthopaedic medication or come from allied health in a related discipline like physiotherapy, look at Orthopaedic implants.

• Shadowing & Market Mapping: Don’t just “apply.” Reach out to Territory Managers and ask to shadow them. Seeing the reality of the role firsthand proves your grit to a hiring manager.

• Upskilling & Education: Use industry-standard training from bodies like the Medical Technology Association of Australia (MTAA) or specialised paid training institutes like the Medical Technology Institute (MTI) to bridge the clinical-commercial knowledge gap.

• Market Intelligence: Listen to legacy resources like the MedTech Mentor podcast to hear the journeys of those who have moved before you, but keep your eye on current industry news via Massdevice and MTPConnect.

Structured Reflection

Before pursuing a transition, assess:

• Can you clearly articulate revenue ownership beyond product familiarity?

• Can you explain margin awareness and procurement dynamics?

• Are you running toward commercial challenge — or reacting to professional fatigue?

• Do you understand how retained mandates move before public advertisement?

The move into MedTech is achievable.

It is rarely accidental.

Transitioning industries is a high-risk move.

Don’t guess. Know.

Before you resign or start applying, audit your Commercial Readiness.

We provide a specific diagnostic tool for emerging talent - healthcare clinicians and pharma professionals ( as well as current Medtech Professionals ).

It assesses your transferrable skills, your commercial expectations, and your readiness to pivot.

Complete our Career Move Readiness Diagnostic - answer some short questions to receive your personal readiness score 📊 .

Find out if you are ready?

When you are operating at, or moving towards, $250k+ roles, you aren’t “job searching”— you are working through a transition.

To land this well, it comes down to how clearly you can align your thinking, your energy, and your commercial value.

For those earlier in the transition, this piece may also be relevant…

1. How People Manage The Process: Search Psychology

The MedTech market is high-touch and often moves slowly.

“Search fatigue” is real—especially for high-performers used to momentum, or those coming back to market after several years.

The people who navigate this well tend to treat it as a strategic process rather than something reactive.

They are clear on what actually matters:

– therapeutic area

– scope

– leadership autonomy

Where that isn’t defined, it’s easy to get pulled into opportunities that don’t quite fit.

They also expect friction.

Clinical timelines shift. Internal approvals stall. Processes take longer than expected.

Those who anticipate that tend to stay composed when things slow down.

And importantly, they maintain their operating rhythm.

Because by the time a real opportunity lands, you’re not just being assessed on experience—you’re being assessed on how you show up.

2. Strategic Alignment: The Interview as a Joint Venture

At this level, interviews aren’t informal conversations—they’re closer to a commercial alignment discussion.

It’s not just about being evaluated. It’s about understanding whether the platform actually supports what you’re trying to build.

That tends to come down to a few things:

– Is there a credible product or pipeline behind the role?

– Does the culture support performance, or recycle people?

– Is there real autonomy, or layers of friction?

How you carry yourself in these conversations matters just as much.

In MedTech, composure under pressure isn’t a soft skill—it’s a core signal. Whether that’s in theatre, with a KOL, or in front of a leadership team.

And the strongest candidates don’t leave the narrative open-ended.

They follow up clearly—linking their experience back to the commercial challenges discussed, and reinforcing why the fit makes sense.

3. How Commercial Impact Is Presented

Regardless of level, one of the clearest differentiators is how commercial impact is articulated.

The strongest profiles are specific.

Not responsibilities—but outcomes.

– revenue growth

– market share shifts

– tenders won

– territories built

If that’s not clear, it’s difficult for a hiring leader to place you commercially.

The same applies to conversations.

People who can clearly connect their experience to real business outcomes tend to stand out quickly.

4: Post-Offer Due Diligence

Getting to offer stage is a position of strength—but it’s also where poor decisions get made if things aren’t properly assessed.

The better operators slow things down here.

They look beyond the headline number and focus on:

– whether the role creates a platform for the next 3–5 years

– how the manager actually operates day to day

– what the broader environment will feel like over time

Because at this level, a misstep isn’t just a bad move—it resets momentum.

This applies just as much to senior individual contributors as it does to leadership roles.

The pattern that shows up

Most missteps at this level don’t come from lack of opportunity.

They come from misalignment that wasn’t picked up early.

The people who navigate this well tend to prioritise clarity over speed.

They’re deliberate about what they’re moving towards—not just what they’re moving away from.

And often, what gets described as a “gut feel” is simply pattern recognition—something not quite lining up beneath the surface.

When that shows up, it’s usually worth paying attention.

Don’t leave your next move to chance.

If you’re feeling friction in the market — or just want to sense-check where you sit — it’s worth taking a step back before pushing forward.

You can position yourself on the 2026 MedTech Talent Map.

It’s one question, and helps build a clearer view of how the market is actually moving.

Position Yourself On the Talent Map 📍

If you want a deeper sense-check, you can also explore the MedTech Market Positioning Scorecard.

Benchmark your value in the invisible market

The “Enduro” Mindset Then & Now

In January 2020, I left a visible legacy medtech recruitment role at an established firm in Sydney to race the Andes-Pacifico in Chile—a multi-day mountain bike enduro challenge.

Racing on “anti-grip” terrain at high altitude taught me a singular truth:

I’d realised the recruitment industry was also running on optimism—racing to send CVs and relying on speed rather than precise navigation.

I didn’t found DukeMed to be another resume-shuffling agency. I founded it to run talent acquisition like an expedition. In the big mountains, you either have the map and the discipline to follow it, or you fail.

I’ve brought that same rigour to the MedTech search market, as “Post-and-Pray” isn’t always a fit-for-purpose option for 2026 and beyond.

We don’t wait for talent to find us; we map the environment, sense-check the reality, and deliver with precision.

The Reality of the Search Led-Intelligence Hiring Pivot

In the early days, I tried to be everything to everyone—offering candidate-led career coaching alongside supporting clients and experimenting with the post-Covid “Rec-Tech” video platforms.

The DukeMed you see today isn’t the one I launched during Covid - I’ve moved beyond the transactional ( and the tech. )

I realised the Medtech industry didn’t need another platform; it needed a search partner with the discipline and conviction to map the landscape before the first interview starts, before the stakes are raised which they are with critical Medtech hires.

The last few months have been a process of stripping back distractions to focus on Standalone Market Modules in addition to search-led hiring.

These are the commercial deep-dives that usually only happen inside a $30k search, now available as unbundled bespoke intelligence reports ( and credited back towards a future search inside your business - you only pay once, not twice ).

Explore the Search Frameworks we deliver at DukeMed :

• 🌐We Map Markets: To ensure you aren’t hiring blind.

• 💰We Audit Market Salaries: To ensure you don’t lose talent to competitors.

• 💗We Check Market Realities: Gathering sentiment so you have the real “pulse check” from the field

And naturally, yes, we also Execute Search in your market or discipline:

Our rigorous, thorough and transparent roadmap for securing the top 15% of the “Invisible Market ” in ~6 weeks.

Explore the Search Intelligence Hub

Our 2026 Commitment: Market-Led Search Intelligence + Best Practice Search Methodology

Whether I am navigating a ridge in the French Alps or mapping a complex commercial territory, the principle is the same:

The best outcomes don’t come from perfection; they come from how fast you adapt, communicate, and reset.

Visibility is the first step to reclaiming control. Which of these hiring ‘friction points’ is currently impacting your team’s commercial momentum?

🔮Your data informs the next briefing. I’ll be sharing the aggregate results of this poll and what they signal for the Q2 MedTech landscape.

In MedTech, there are two distinct hiring ecosystems operating in parallel:

1. The Visible Market:

   Reactive, noisy, and high-volume. It’s where 90% of candidates compete for the 20% of roles that hit LinkedIn.

2. The Invisible Market (Search):

   This is where DukeMed operates. Senior leadership or niche clinical roles that are filled via bespoke Search & Market Mapping—not volume job ads or boards

The Border Chase

Most of you know me from my 17-year tenure in one seat in Sydney, mapping the MedTech landscape. But there was a pivot point. During the height of the lockdowns, I spent 70 days overland, chasing open state borders across the Gulf Savannah and the tropics—from Central QLD to Darwin and back.

I came back from that 70-day chase across the Gulf Savannah with a clean slate. What followed was a period of intense incubation—personally and professionally. My second child was born, and DukeMed was conceived.

I didn’t just want to 'get back to work'; I wanted to build a model that respected the weight of these life-changing transitions—for you, and for the clients I partner with.

Navigating the tropics when the maps are changing in real-time teaches you one thing:

The best outcomes don’t come from perfection; they come from how fast you adapt and communicate.

I’ve applied that same "MTB Enduro" mindset to the relaunch of the DukeMed website and engagement framework.

I’ve spent the time since mid-2023—and specifically the recent summer reset—refining a model that respects your time as much as it respects the client’s bottom line.

The “Hard Cut”: Why I’ve Changed How I Work

In the past, recruitment was often about “dangling carrots”—gossip and “maybes.”

As a solo operator, I’ve made a Hard Cut. I have moved from “chats” to Search Intelligence.

• Context Over CVs: I want to understand your trajectory before we even look at a job spec.

• Truth as a Standard: If a search mandate isn’t a 100% “Grip” match for you, I’ll tell you early. No loops. No “limbo.”

• Data Over Gossip: I provide diagnostics and market insights to help you position yourself, so you don’t have to “chase” roles.

The Framework of Engagement

I am a one-man band by design. This allows me to go deep—not wide. My engagement follows a structured path:

Self-Guided: Diagnostics to help you sense-check your position privately.

Contextual: Short, focused conversations to surface reality, not to “intake” you into a database.

Search-Led: Visibility only within defined, committed mandates where alignment is verified.

Audit Your Market Positioning

• Move beyond a simple poll and understand how your specific trajectory aligns with the 2026 “Invisible Market,” I invite you to audit your position readiness via the MedTech Market Positioning Scorecard.

  If you want to benchmark how your profile is currently positioned within retained mandates and emerging demand pockets, the MedTech Market Positioning Scorecard provides a structured, independent view of your market alignment.

  Begin

Share Inside MedTech Hiring

Share

Over recent weeks, we’ve wrapped up the Ortho Moves Index 💬, one of the most comprehensive looks yet at what’s driving career movement across Australia’s orthopaedic sales market.

The insights from that project, plus ongoing search-led hiring conversations, are already showing clear signals 🛜 about what’s ahead.

It’s already sparked some interesting conversations with hiring leaders across Australia.

If you’d like to see the full Ortho Moves Index employer deck — with anonymised insights from across ANZ — just click the “Message Richard” button below and I’ll send you a copy directly.

We’re now heading into the busiest part of the year with only 46 working days left in 2025.⚡️📆 — when new budgets, restructures, and quiet career moves collide. Over the coming weeks, you’ll see fresh Hiring Signals episodes 🎧 and short audio posts tracking salary shifts, sentiment changes, and the noise behind the numbers.

I’ll also be sharing a few audio versions of earlier posts and articles ⏪—think of them as a back catalogue of the topics that started it all, in bite-sized, easy-to-listen-to, and follow-along chunks.

PS (Later this year, I’ll also launch a separate channel focused on candidate perspectives and career direction — stay tuned for that.)

Share Inside MedTech Hiring

Meanwhile, candidates are often sitting quietly, waiting—uncertain whether to move, whether they’re still relevant, or whether anything better is really out there.

---

Why I started this newsletter:

I’m Richard Duke, and I run DukeMed Pty Ltd—a search-led recruitment firm focused on solving Medtech commercial and leadership “hiring headaches” across Australia (and the APAC region). Each week, I speak with hiring leaders, talented candidates, and HR execs about what’s actually happening on the ground & how to improve.

Inside MedTech Hiring exists to share those patterns:

• Salary pressure that’s not visible in published bands

• Shifts in candidate sentiment—what they’re valuing, fearing, or ignoring

• Hiring blind spots that cost companies standout talent

• And the quiet moves happening behind the scenes

What to expect:

• 📌 Short signal-led posts or audio soundbites (1–2x per week tops)

• 📈 Market movement summaries, drawn from live search work or market index surveys & quiz

• 🎯 Practical, honest takeaways—no fluff, no preaching

Free content will land regularly.

Paid insight reports and strategy drops are coming soon—for those who want to stay ahead of the market before it shifts again.

Thanks for being here.

— Richard

Subscribe now